Integrated bioinformatics, computational and experimental methods to discover novel Raf/extracellular-signal regulated kinase (ERK) dual inhibitors against breast cancer cells

The integrated in silico design, chemical synthesis, biological screening and proteomics analysis as an attractive strategy for discovery dual inhibitors of Raf1 and ERK against breast cancer.167